ClinicalTrials HQ

Aliso Viejo

Aliso Viejo

Aliso Viejo, California, United States

13 results · Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Observational Study of Individuals With Isolated DystoniaDyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, dystonic disorder, inherited torticollis, movement disorder, nervous system disorderActive, not recruitingNot stated2026-09-21NCT07111663
Product Surveillance RegistryAneurysm, Arterial Occlusive Diseases, Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, arteriosclerosis disorder, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, intracranial arterial disease, kidney disorder, kidney failure, myocardial ischemia, nervous system disorder, otorhinolaryngologic disease, urinary system disorder, vascular disorderRecruitingNot stated2026-09-18NCT01524276
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingNot stated2026-09-16NCT02071134
A Clinical Study Evaluating Licaminlimab for Dry Eye Diseasedry eye syndrome, eye disorder, lacrimal apparatus disorderRecruitingPhase 2 / Phase 32026-08-28NCT07548632
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migrainebrain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorderActive, not recruitingNot stated2026-06-01NCT06543914
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyActive, not recruitingPhase 22026-04-23NCT06773962
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyActive, not recruitingPhase 32026-04-17NCT06553027
TB006 for Autism Spectrum Disorderautism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorderRecruitingPhase 22026-04-14NCT06500637
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's DiseaseParasomnias, Parkinson disease, REM Sleep Parasomnias, REM sleep behavior disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, sleep-wake disorder, synucleinopathyActive, not recruitingNot stated2026-02-11NCT06621602
Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacksbrain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorderRecruitingNot stated2026-02-10NCT07310290
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingNot stated2025-10-22NCT07219927
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingPhase 42025-08-24NCT06765668
Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the LVIS DeviceAneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorderEnrolling by invitationNot stated2025-06-17NCT05453240